Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Polycystic Ovary Syndrome × semaglutide × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Obesity 1

Interventions

Metformin 5 empagliflozin 2 Tablets 2 Letrozole 2 Clomiphene 2 thymoquinone 1 semaglutide 1 penclomedine 1 Vaginal Creams, Foams, and Jellies 1 Sitagliptin Phosphate 1 Ovidrel 1 Inositol 1 Folic Acid 1 Exenatide 1 Curcumin 1 Crinone 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2/3 Recruiting

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡